skip to Main Content

Vaccine “made in Pomezia” tested on children and the elderly

Vaccine “made In Pomezia” Tested On Children And The Elderly
fonte foto:

il Caffè.tv

The vaccine against Covid-19 developed by the University of Oxford in collaboration with IRBM in Pomezia (Rome) will now be tested on children and the elderly. Phase 1 of clinical trials had involved 1.000 adults under 55 years old. Now over 10.200 people of different age groups (56-69, over 70 and between 5-12 years) will be enrolled and the vaccine effects on the immune system will be evaluated. Good outcomes from tests on monkeys, which hopefully can be replicated on humans.

Article published on – 23/05/2020

Read the original article on

Back To Top